Jean-Paul (John) Audette
Chief Executive Officer
Mr. Audette joined MitoSciences in May of 2006. Prior to that he was the Founder and Managing Director in 2003 of Audette Group Consulting, a strategic consultancy for early-stage high technology companies. Beginning in 1999 Mr. Audette was a Senior Vice President at Outrider (now WPP) part of Tempus Group Plc, an international marketing services conglomerate based in London. Beginning in 1994 Mr. Audette was the Sr. Vice President and Chief Strategist at MMG Inc. until its acquisition by Outrider/Tempus in 1999. Prior to MMG Mr. Audette held various marketing management positions with information services companies JWP and PCX. Mr. Audette has a B.A. in human ecology from the University of Oregon and is a licensed Emergency Medical Technician.

Roderick A. Capaldi, D.Phil.
Chief Scientific Officer
Dr. Capaldi was educated at London University (BSc) and York University (D.Phil.). He is Knight Professor of the Arts and Sciences and member of the prestigious Institute of Molecular Biology at the University of Oregon. Publisher of more than 200 papers in the area of mitochondrial function and disease, Dr. Capaldi has been Established Investigator of the American Heart Association and recipient of the Medical Research Foundation of Oregon Medal.

Michael F. Marusich, Ph.D.
Chief Operations Officer
Dr. Marusich received his BS in Zoology from the University of Michigan in 1975 and M.S. and Ph.D. degrees in Biology from Northwestern University in 1976 and 1981 respectively. Since 1986 Dr. Marusich has served as the Director of the Monoclonal Antibody Facility of the University of Oregon. Dr. Marusich has published more than 30 papers on the development of novel immunoassays and techniques and on immunochemical-based research of early development and mitochondrial disorders.

James G. Murray, Ph.D.
Senior Director, Research & Development
Dr. Murray joined MitoSciences in 2003. Prior to that he served as a post-doctoral research associate in the Institute of Molecular Biology at the University of Oregon where he has studied the organization of the multi-subunit enzymes of oxidative phosphorylation as well as developing novel methods to generate and characterize antibodies for the isolation of these complexes. Dr. Murray graduated from the University of Edinburgh, UK, in 1994 with a B.Sc. honors degree in Biochemistry. In 1998 he was awarded a Ph.D. from the University of Leeds, UK, for studies upon the structure/function of the yeast vacuolar type ATPase under the supervision of Prof. J. B. C. Findlay.

Kristina (Tina) Hahn, Ph.D.
Director, Production
Dr. Hahn joined MitoSciences in February of 2007. Prior to that Dr. Hahn was a Manager/Principal Scientist at Roche Molecular Systems beginning in 2001 where she was responsible for process development and manufacture of PCR enzymes for in-vitro diagnostic products. Prior to Roche Dr. Hahn spent two years at Colgate-Palmolive where she developed real-time quantitative PCR tools to evaluate new oral care products. Dr. Hahn received her B.S. in Biology from Northern Illinois University in 1994, and her M.S. in 1996 and Ph.D. in 1999 in Microbiology & Immunology from the University of Rochester.

Denice Gray, M.S., C.P.A.
Director, Finance and Controller
Ms. Gray joined MitoSciences in August 2007. Prior to that, Ms. Gray was a CPA for 7 years at Moss Adams LLP. She has experience in financial statements, taxation and consulting, and has concentrated her career on commercial enterprises, including manufacturing and construction companies. Before becoming a CPA, Ms. Gray was an economist for various government agencies and research organizations, including the Federal Reserve Board and the U.S. Department of Agriculture. She has received a B.A. in economics from Pomona College and a M.S. in economics from the University of Wisconsin, Madison. She also had course work in accounting at the University of Oregon and is a member of the American Institute of Certified Public Accountants.